willytheg

Even Fatter Yields for Pfizer; M&A Targets in the Sector

Anybody out there follow a little biomed in Petaluma, CA named Oculus Innovative Sciences OCLS. From the DD I've done on the fundamentals of their product they are ripe for either a tenfold increase in pps or one of the bigger biotech companies are going to make ground floor execs and shareholders very wealthy.

They have developed a safe, inexpensive and effective platform to deal with MRSA, MSSA, VRE named "Microcyn". It's currently deployed or about to be deployed in China, India, and Mexico.

I'd love for somebody to check this out and tell me it's voodoo while it's still under $2/share. It was up 10% on the day the DJIA was down 773 last week.